48,874 Shares in Sabra Healthcare REIT, Inc. $SBRA Purchased by Pensionfund Sabic

Pensionfund Sabic acquired a new position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 48,874 shares of the real estate investment trust’s stock, valued at approximately $926,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Focus Partners Wealth lifted its position in Sabra Healthcare REIT by 11.4% in the first quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock valued at $404,000 after purchasing an additional 2,375 shares during the period. Creative Planning increased its position in Sabra Healthcare REIT by 17.2% during the 2nd quarter. Creative Planning now owns 35,175 shares of the real estate investment trust’s stock worth $649,000 after purchasing an additional 5,168 shares during the period. Cetera Investment Advisers increased its position in Sabra Healthcare REIT by 2.1% during the 2nd quarter. Cetera Investment Advisers now owns 107,152 shares of the real estate investment trust’s stock worth $1,976,000 after purchasing an additional 2,203 shares during the period. Franklin Resources Inc. raised its stake in shares of Sabra Healthcare REIT by 27.4% during the 2nd quarter. Franklin Resources Inc. now owns 503,499 shares of the real estate investment trust’s stock worth $9,285,000 after buying an additional 108,268 shares in the last quarter. Finally, Rhumbline Advisers raised its stake in shares of Sabra Healthcare REIT by 3.5% during the 2nd quarter. Rhumbline Advisers now owns 874,361 shares of the real estate investment trust’s stock worth $16,123,000 after buying an additional 29,846 shares in the last quarter. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

SBRA has been the subject of a number of recent analyst reports. Weiss Ratings raised Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (a-)” rating in a report on Wednesday, March 18th. Citizens Jmp increased their price target on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a report on Wednesday, February 18th. Jefferies Financial Group reiterated a “buy” rating and issued a $22.00 price objective on shares of Sabra Healthcare REIT in a research note on Monday, December 15th. UBS Group upped their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a research report on Thursday, February 19th. Finally, Wall Street Zen lowered shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Friday, January 23rd. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $21.90.

Sabra Healthcare REIT Trading Up 0.6%

NASDAQ:SBRA opened at $19.84 on Thursday. The company has a market capitalization of $5.00 billion, a PE ratio of 31.00, a price-to-earnings-growth ratio of 1.57 and a beta of 0.64. The company has a quick ratio of 4.29, a current ratio of 4.29 and a debt-to-equity ratio of 0.90. Sabra Healthcare REIT, Inc. has a 52-week low of $15.75 and a 52-week high of $21.07. The stock has a fifty day simple moving average of $19.77 and a 200-day simple moving average of $19.07.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings data on Thursday, February 12th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.26). Sabra Healthcare REIT had a return on equity of 5.63% and a net margin of 20.09%.The business had revenue of $201.35 million during the quarter, compared to analysts’ expectations of $201.97 million. During the same quarter in the prior year, the firm earned $0.36 earnings per share. Sabra Healthcare REIT’s quarterly revenue was up 16.2% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, equities research analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 27th. Stockholders of record on Friday, February 13th were paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.0%. The ex-dividend date of this dividend was Friday, February 13th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 187.50%.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.